{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:41:10Z","timestamp":1790959270475,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,4,8]],"date-time":"2014-04-08T00:00:00Z","timestamp":1396915200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2407-14-246","type":"journal-article","created":{"date-parts":[[2014,4,8]],"date-time":"2014-04-08T03:01:47Z","timestamp":1396926107000},"source":"Crossref","is-referenced-by-count":45,"title":["Gene expression profiling reveals activation of the FA\/BRCA pathway in advanced squamous cervical cancer with intrinsic resistance and therapy failure"],"prefix":"10.1186","volume":"14","author":[{"given":"Ovidiu","family":"Balacescu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Balacescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oana","family":"Tudoran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolae","family":"Todor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meda","family":"Rus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rares","family":"Buiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergiu","family":"Susman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan","family":"Fetica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Maja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Visan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Ordeanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana","family":"Berindan-Neagoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viorica","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,8]]},"reference":[{"key":"4482_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin. 2011, 61: 69-90. 10.3322\/caac.20107.","journal-title":"CA Cancer J Clin"},{"key":"4482_CR2","first-page":"261","volume":"58","author":"TH Lippert","year":"2008","unstructured":"Lippert TH, Ruoff HJ, Volm M: Intrinsic and acquired drug resistance in malignant tumors. The main reason for therapeutic failure. Arzneimittelforschung. 2008, 58: 261-264.","journal-title":"Arzneimittelforschung"},{"key":"4482_CR3","volume-title":"Cancer Facts & Figures 2012","author":"American Cancer Society","year":"2012","unstructured":"American Cancer Society: Cancer Facts & Figures 2012. 2012, Atlanta: American Cancer Society"},{"key":"4482_CR4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nrm2351","volume":"9","author":"D Branzei","year":"2008","unstructured":"Branzei D, Foiani M: Regulation of DNA repair throughout the cell cycle. Nat Rev Mol Cell Biol. 2008, 9: 297-308. 10.1038\/nrm2351.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4482_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ygyno.2008.01.027","volume":"109","author":"K Zempolich","year":"2008","unstructured":"Zempolich K, Fuhrman C, Milash B, Flinner R, Greven K, Ryu J, Forbes A, Kerlin K, Nichols RC, Gaffney DK: Changes in gene expression induced by chemoradiation in advanced cervical carcinoma: a microarray study of RTOG C-0128. Gynecol Oncol. 2008, 109: 275-279. 10.1016\/j.ygyno.2008.01.027.","journal-title":"Gynecol Oncol"},{"key":"4482_CR6","first-page":"5486","volume":"9","author":"YF Wong","year":"2003","unstructured":"Wong YF, Selvanayagam ZE, Wei N, Porter J, Vittal R, Hu R, Lin Y, Liao J, Shih JW, Cheung TH, Lo KW, Yim SF, Yip SK, Ngong DT, Siu N, Chan LK, Chan CS, Kong T, Kutlina E, McKinnon RD, Denhardt DT, Chin KV, Chung TK: Expression genomics of cervical cancer: molecular classification and prediction of radiotherapy response by DNA microarray. Clin Cancer Res. 2003, 9: 5486-5492.","journal-title":"Clin Cancer Res"},{"key":"4482_CR7","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S1028-4559(08)60005-4","volume":"46","author":"A Chao","year":"2007","unstructured":"Chao A, Wang TH, Lai CH: Overview of microarray analysis of gene expression and its applications to cervical cancer investigation. Taiwan J Obstet Gynecol. 2007, 46: 363-373. 10.1016\/S1028-4559(08)60005-4.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"4482_CR8","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001, 25: 402-408. 10.1006\/meth.2001.1262.","journal-title":"Methods"},{"key":"4482_CR9","doi-asserted-by":"publisher","first-page":"R56","DOI":"10.1186\/bcr2615","volume":"12","author":"VJ Tuominen","year":"2010","unstructured":"Tuominen VJ, Ruotoistenmaki S, Viitanen A, Jumppanen M, Isola J: ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67. Breast Cancer Res. 2010, 12: R56-10.1186\/bcr2615.","journal-title":"Breast Cancer Res"},{"key":"4482_CR10","volume-title":"Fundamentals of biostatistics","author":"B Rosner","year":"2006","unstructured":"Rosner B: Fundamentals of biostatistics. 2006, Pacific Grove, CA: Duxbury Press, 6","edition":"6"},{"key":"4482_CR11","volume-title":"Statistical evaluation of Diagnostic performance topics in ROC Analysis","author":"KH Zou","year":"2012","unstructured":"Zou KH, Liu A, Bandos AI, Ohno-Machado L, Rockette HE: Statistical evaluation of Diagnostic performance topics in ROC Analysis. 2012, Boca Raton, Florida: Chapman & Hall\/CRC Press"},{"key":"4482_CR12","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/0022-2496(75)90001-2","volume":"12","author":"D Bamber","year":"1975","unstructured":"Bamber D: The area above the ordinal dominance graph and the area below the receiver operating characteristics graph. J Math Psychol. 1975, 12: 387-415. 10.1016\/0022-2496(75)90001-2.","journal-title":"J Math Psychol"},{"key":"4482_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","volume":"143","author":"JA Hanley","year":"1982","unstructured":"Hanley JA, McNeil BJ: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiol. 1982, 143: 29-36.","journal-title":"Radiol"},{"key":"4482_CR14","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/sj.onc.1210700","volume":"27","author":"A Kauffmann","year":"2008","unstructured":"Kauffmann A, Rosselli F, Lazar V, Winnepenninckx V, Mansuet-Lupo A, Dessen P, van den Oord JJ, Spatz A, Sarasin A: High expression of DNA repair pathways is associated with metastasis in melanoma patients. Oncogene. 2008, 27: 565-573. 10.1038\/sj.onc.1210700.","journal-title":"Oncogene"},{"key":"4482_CR15","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1200\/JCO.2005.03.2375","volume":"24","author":"M Sanchez-Carbayo","year":"2006","unstructured":"Sanchez-Carbayo M, Socci ND, Lozano J, Saint F, Cordon-Cardo C: Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. J Clin Oncol. 2006, 24: 778-789. 10.1200\/JCO.2005.03.2375.","journal-title":"J Clin Oncol"},{"key":"4482_CR16","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1634\/theoncologist.2012-0028","volume":"17","author":"G Rigakos","year":"2012","unstructured":"Rigakos G, Razis E: BRCAness: finding the Achilles heel in ovarian cancer. Oncologist. 2012, 17: 956-962. 10.1634\/theoncologist.2012-0028.","journal-title":"Oncologist"},{"key":"4482_CR17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nrc3181","volume":"12","author":"R Roy","year":"2012","unstructured":"Roy R, Chun J, Powell SN: BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nat Rev Cancer. 2012, 12: 68-78.","journal-title":"Nat Rev Cancer"},{"key":"4482_CR18","doi-asserted-by":"publisher","first-page":"33165","DOI":"10.1074\/jbc.M505124200","volume":"280","author":"Y Zhang","year":"2005","unstructured":"Zhang Y, Fan S, Meng Q, Ma Y, Katiyar P, Schlegel R, Rosen EM: BRCA1 interaction with human papillomavirus oncoproteins. J Biol Chem. 2005, 280: 33165-33177. 10.1074\/jbc.M505124200.","journal-title":"J Biol Chem"},{"key":"4482_CR19","doi-asserted-by":"publisher","first-page":"e30042","DOI":"10.1371\/journal.pone.0030042","volume":"7","author":"WZ Wysham","year":"2012","unstructured":"Wysham WZ, Mhawech-Fauceglia P, Li H, Hays L, Syriac S, Skrepnik T, Wright J, Pande N, Hoatlin M, Pejovic T: BRCAness profile of sporadic ovarian cancer predicts disease recurrence. PLoS One. 2012, 7: e30042-10.1371\/journal.pone.0030042.","journal-title":"PLoS One"},{"key":"4482_CR20","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1101\/gad.14.8.927","volume":"14","author":"Y Wang","year":"2000","unstructured":"Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ, Qin J: BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev. 2000, 14: 927-939.","journal-title":"Genes Dev"},{"key":"4482_CR21","doi-asserted-by":"publisher","first-page":"R668","DOI":"10.1016\/S0960-9822(01)00389-X","volume":"11","author":"P Kerr","year":"2001","unstructured":"Kerr P, Ashworth A: New complexities for BRCA1 and BRCA2. Curr Biol. 2001, 11: R668-R676. 10.1016\/S0960-9822(01)00389-X.","journal-title":"Curr Biol"},{"key":"4482_CR22","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.dnarep.2012.12.007","volume":"12","author":"RB Jensen","year":"2013","unstructured":"Jensen RB, Ozes A, Kim T, Estep A, Kowalczykowski SC: BRCA2 is epistatic to the RAD51 paralogs in response to DNA damage. DNA Repair (Amst). 2013, 12: 306-311. 10.1016\/j.dnarep.2012.12.007.","journal-title":"DNA Repair (Amst)"},{"key":"4482_CR23","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1101\/gad.195248.112","volume":"26","author":"H Kim","year":"2012","unstructured":"Kim H, D\u2019Andrea AD: Regulation of DNA cross-link repair by the Fanconi anemia\/BRCA pathway. Genes Dev. 2012, 26: 1393-1408. 10.1101\/gad.195248.112.","journal-title":"Genes Dev"},{"key":"4482_CR24","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/nrg2159","volume":"8","author":"W Wang","year":"2007","unstructured":"Wang W: Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet. 2007, 8: 735-748. 10.1038\/nrg2159.","journal-title":"Nat Rev Genet"},{"key":"4482_CR25","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.dnarep.2009.01.019","volume":"8","author":"AF Alpi","year":"2009","unstructured":"Alpi AF, Patel KJ: Monoubiquitylation in the Fanconi anemia DNA damage response pathway. DNA Repair (Amst). 2009, 8: 430-435. 10.1016\/j.dnarep.2009.01.019.","journal-title":"DNA Repair (Amst)"},{"key":"4482_CR26","doi-asserted-by":"publisher","first-page":"e36970","DOI":"10.1371\/journal.pone.0036970","volume":"7","author":"IR Kelsall","year":"2012","unstructured":"Kelsall IR, Langenick J, MacKay C, Patel KJ, Alpi AF: The Fanconi anaemia components UBE2T and FANCM are functionally linked to nucleotide excision repair. PLoS One. 2012, 7: e36970-10.1371\/journal.pone.0036970.","journal-title":"PLoS One"},{"key":"4482_CR27","doi-asserted-by":"publisher","first-page":"5078","DOI":"10.1182\/blood-2010-10-311761","volume":"117","author":"SA Williams","year":"2011","unstructured":"Williams SA, Longerich S, Sung P, Vaziri C, Kupfer GM: The E3 ubiquitin ligase RAD18 regulates ubiquitylation and chromatin loading of FANCD2 and FANCI. Blood. 2011, 117: 5078-5087. 10.1182\/blood-2010-10-311761.","journal-title":"Blood"},{"key":"4482_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cell.2009.06.030","volume":"138","author":"JM Svendsen","year":"2009","unstructured":"Svendsen JM, Smogorzewska A, Sowa ME, O\u2019Connell BC, Gygi SP, Elledge SJ, Harper JW: Mammalian BTBD12\/SLX4 assembles a Holliday junction resolvase and is required for DNA repair. Cell. 2009, 138: 63-77. 10.1016\/j.cell.2009.06.030.","journal-title":"Cell"},{"key":"4482_CR29","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.cell.2009.06.029","volume":"138","author":"S Fekairi","year":"2009","unstructured":"Fekairi S, Scaglione S, Chahwan C, Taylor ER, Tissier A, Coulon S, Dong MQ, Ruse C, Yates JR, Russell P, Fuchs RP, McGowan CH, Gaillard PH: Human SLX4 is a Holliday junction resolvase subunit that binds multiple DNA repair\/recombination endonucleases. Cell. 2009, 138: 78-89. 10.1016\/j.cell.2009.06.029.","journal-title":"Cell"},{"key":"4482_CR30","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1158\/0008-5472.CAN-04-0245","volume":"64","author":"G Narayan","year":"2004","unstructured":"Narayan G, Arias-Pulido H, Nandula SV, Basso K, Sugirtharaj DD, Vargas H, Mansukhani M, Villella J, Meyer L, Schneider A, Gissmann L, D\u00fcrst M, Pothuri B, Murty VV: Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer. Cancer Res. 2004, 64: 2994-2997. 10.1158\/0008-5472.CAN-04-0245.","journal-title":"Cancer Res"},{"key":"4482_CR31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1476-4598-11-26","volume":"11","author":"C Jacquemont","year":"2012","unstructured":"Jacquemont C, Simon JA, D\u2019Andrea AD, Taniguchi T: Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin. Mol Cancer. 2012, 11: 26-10.1186\/1476-4598-11-26.","journal-title":"Mol Cancer"},{"key":"4482_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0300-483X(03)00291-9","volume":"193","author":"W Henning","year":"2003","unstructured":"Henning W, Sturzbecher HW: Homologous recombination and cell cycle checkpoints: Rad51 in tumour progression and therapy resistance. Toxicology. 2003, 193: 91-109. 10.1016\/S0300-483X(03)00291-9.","journal-title":"Toxicology"},{"key":"4482_CR33","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s12032-010-9605-1","volume":"28","author":"LQ Du","year":"2011","unstructured":"Du LQ, Wang Y, Wang H, Cao J, Liu Q, Fan FY: Knockdown of Rad51 expression induces radiation- and chemo-sensitivity in osteosarcoma cells. Med Oncol. 2011, 28: 1481-1487. 10.1007\/s12032-010-9605-1.","journal-title":"Med Oncol"},{"key":"4482_CR34","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.canlet.2004.08.009","volume":"218","author":"C Richardson","year":"2005","unstructured":"Richardson C: RAD51, genomic stability, and tumorigenesis. Cancer Lett. 2005, 218: 127-139. 10.1016\/j.canlet.2004.08.009.","journal-title":"Cancer Lett"},{"key":"4482_CR35","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1002\/ijc.27907","volume":"132","author":"P Tennstedt","year":"2013","unstructured":"Tennstedt P, Fresow R, Simon R, Marx A, Terracciano L, Petersen C, Sauter G, Dikomey E, Borgmann K: RAD51 overexpression is a negative prognostic marker for colorectal adenocarcinoma. Int J Cancer. 2013, 132: 2118-2126. 10.1002\/ijc.27907.","journal-title":"Int J Cancer"},{"key":"4482_CR36","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1158\/1535-7163.MCT-06-0636","volume":"6","author":"JA Hannay","year":"2007","unstructured":"Hannay JA, Liu J, Zhu QS, Bolshakov SV, Li L, Pisters PW, Lazar AJ, Yu D, Pollock RE, Lev D: Rad51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53\/activator protein 2 transcriptional regulation. Mol Cancer Ther. 2007, 6: 1650-1660. 10.1158\/1535-7163.MCT-06-0636.","journal-title":"Mol Cancer Ther"},{"key":"4482_CR37","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/ijc.25736","volume":"129","author":"R Barbano","year":"2011","unstructured":"Barbano R, Copetti M, Perrone G, Pazienza V, Muscarella LA, Balsamo T, Storlazzi CT, Ripoli M, Rinaldi M, Valori VM, Latiano TP, Maiello E, Stanziale P, Carella M, Mangia A, Pellegrini F, Bisceglia M, Muda AO, Altomare V, Murgo R, Fazio VM, Parrella P: High RAD51 mRNA expression characterize estrogen receptor-positive\/progesteron receptor-negative breast cancer and is associated with patient's outcome. Int J Cancer. 2011, 129: 536-545. 10.1002\/ijc.25736.","journal-title":"Int J Cancer"},{"key":"4482_CR38","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/sj.bjc.6602665","volume":"93","author":"GB Qiao","year":"2005","unstructured":"Qiao GB, Wu YL, Yang XN, Zhong WZ, Xie D, Guan XY, Fischer D, Kolberg HC, Kruger S, Stuerzbecher HW: High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients. Br J Cancer. 2005, 93: 137-143. 10.1038\/sj.bjc.6602665.","journal-title":"Br J Cancer"},{"key":"4482_CR39","first-page":"7377","volume":"63","author":"JS Russell","year":"2003","unstructured":"Russell JS, Brady K, Burgan WE, Cerra MA, Oswald KA, Camphausen K, Tofilon PJ: Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity. Cancer Res. 2003, 63: 7377-7383.","journal-title":"Cancer Res"},{"key":"4482_CR40","doi-asserted-by":"publisher","first-page":"20810","DOI":"10.1073\/pnas.0807990106","volume":"105","author":"CM Hine","year":"2008","unstructured":"Hine CM, Seluanov A, Gorbunova V: Use of the Rad51 promoter for targeted anti-cancer therapy. Proc Natl Acad Sci U S A. 2008, 105: 20810-20815. 10.1073\/pnas.0807990106.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4482_CR41","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.molmed.2008.02.003","volume":"14","author":"J Yelamos","year":"2008","unstructured":"Yelamos J, Schreiber V, Dantzer F: Toward specific functions of poly(ADP-ribose) polymerase-2. Trends Mol Med. 2008, 14: 169-178. 10.1016\/j.molmed.2008.02.003.","journal-title":"Trends Mol Med"},{"key":"4482_CR42","first-page":"301","volume":"1","author":"X Wang","year":"2011","unstructured":"Wang X, Weaver DT: The ups and downs of DNA repair biomarkers for PARP inhibitor therapies. Am J Cancer Res. 2011, 1: 301-327.","journal-title":"Am J Cancer Res"},{"key":"4482_CR43","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.2174\/138945011798829438","volume":"12","author":"SK Sandhu","year":"2011","unstructured":"Sandhu SK, Yap TA, de Bono JS: The emerging role of poly (ADP-Ribose) polymerase inhibitors in cancer treatment. Curr Drug Targets. 2011, 12: 2034-2044. 10.2174\/138945011798829438.","journal-title":"Curr Drug Targets"},{"key":"4482_CR44","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0167-8140(95)01535-O","volume":"35","author":"AW Fyles","year":"1995","unstructured":"Fyles AW, Pintilie M, Kirkbride P, Levin W, Manchul LA, Rawlings GA: Prognostic factors in patients with cervix cancer treated by radiation therapy: results of a multiple regression analysis. Radiother Oncol. 1995, 35: 107-117. 10.1016\/0167-8140(95)01535-O.","journal-title":"Radiother Oncol"},{"key":"4482_CR45","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1525-1438.2006.00379.x","volume":"16","author":"K Narayan","year":"2006","unstructured":"Narayan K, Fisher R, Bernshaw D: Significance of tumor volume and corpus uteri invasion in cervical cancer patients treated by radiotherapy. Int J Gynecol Cancer. 2006, 16: 623-630. 10.1111\/j.1525-1438.2006.00379.x.","journal-title":"Int J Gynecol Cancer"},{"key":"4482_CR46","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/1471-2407-7-234","volume":"7","author":"R Grigiene","year":"2007","unstructured":"Grigiene R, Valuckas KP, Aleknavicius E, Kurtinaitis J, Letautiene SR: The value of prognostic factors for uterine cervical cancer patients treated with irradiation alone. BMC Cancer. 2007, 7: 234-10.1186\/1471-2407-7-234.","journal-title":"BMC Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-246.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-14-246\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-246","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:14:17Z","timestamp":1648779257000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-14-246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,8]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["4482"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-14-246","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,8]]},"article-number":"246"}}